dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.contributor | University of Waterloo | |
dc.contributor | Universidade de São Paulo (USP) | |
dc.date.accessioned | 2015-12-07T15:37:50Z | |
dc.date.available | 2015-12-07T15:37:50Z | |
dc.date.created | 2015-12-07T15:37:50Z | |
dc.date.issued | 2015-09-10 | |
dc.identifier | Muscle & Nerve, p. 1-28, 2015. | |
dc.identifier | 1097-4598 | |
dc.identifier | http://hdl.handle.net/11449/131571 | |
dc.identifier | 10.1002/mus.24906 | |
dc.identifier | 26355638 | |
dc.description.abstract | We investigated the effects of high-intensity resistance training (RT) on dexamethasone (DEX) induced muscle atrophy in flexor hallucis longus (FHL), tibialis anterior (TA), and soleus (SOL) muscles. Rats underwent either high-intensity RT or were kept sedentary. In the last 10 days they received either DEX (0.5 mg/kg/d, i.p.) or saline. DEX reduced body weight (-21%), food intake (-28%), FHL and TA muscle mass (-20% and -18%), and increased in muscle-specific ring finger 1 (MuRF-1) protein level (+37% and +45.5%). RT attenuated FHL muscle atrophy by a combination of a low increase in MuRF-1 protein level (-3.5%) and significant increases in mammalian target of rapamycin (mTOR) (+63%) and p70S6K (+46% and +49% for Ctrl and DEX) protein levels. The data show that RT attenuated DEX-induced muscle atrophy by a combination of increases in mTOR and p70S6K protein level and a low increase in MuRF-1 protein level. This article is protected by copyright. All rights reserved. | |
dc.language | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation | Muscle & Nerve | |
dc.relation | 1,072 | |
dc.rights | Acesso restrito | |
dc.source | PubMed | |
dc.subject | Glucocorticoids | |
dc.subject | Ladder climbing | |
dc.subject | Muscle atrophy | |
dc.subject | Resistance training | |
dc.subject | Skeletal muscle | |
dc.title | High-intensity resistance training attenuates dexamethasone-induced muscle atrophy | |
dc.type | Artículos de revistas | |